268 related articles for article (PubMed ID: 17493633)
21. Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation.
Jabs A; Göbel S; Wenzel P; Kleschyov AL; Hortmann M; Oelze M; Daiber A; Münzel T
J Am Coll Cardiol; 2008 Jun; 51(22):2130-8. PubMed ID: 18510959
[TBL] [Abstract][Full Text] [Related]
22. p22phox-derived superoxide mediates enhanced proliferative capacity of diabetic vascular smooth muscle cells.
Jeong HY; Jeong HY; Kim CD
Diabetes Res Clin Pract; 2004 Apr; 64(1):1-10. PubMed ID: 15036821
[TBL] [Abstract][Full Text] [Related]
23. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C.
Heitzer T; Wenzel U; Hink U; Krollner D; Skatchkov M; Stahl RA; MacHarzina R; Bräsen JH; Meinertz T; Münzel T
Kidney Int; 1999 Jan; 55(1):252-60. PubMed ID: 9893134
[TBL] [Abstract][Full Text] [Related]
24. Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gialpha protein.
Saha S; Li Y; Lappas G; Anand-Srivastava MB
J Mol Cell Cardiol; 2008 Feb; 44(2):336-44. PubMed ID: 18162186
[TBL] [Abstract][Full Text] [Related]
25. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
Henry PJ; Horowitz JD; Louis WJ
J Pharmacol Exp Ther; 1989 Feb; 248(2):762-8. PubMed ID: 2563771
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells.
Selemidis S; Dusting GJ; Peshavariya H; Kemp-Harper BK; Drummond GR
Cardiovasc Res; 2007 Jul; 75(2):349-58. PubMed ID: 17568572
[TBL] [Abstract][Full Text] [Related]
27. NAD(P)H oxidase-induced oxidative stress in sympathetic ganglia of apolipoprotein E deficient mice.
Ma X; Zhang HJ; Whiteis CA; Tian X; Davisson RL; Kregel KC; Abboud FM; Chapleau MW
Auton Neurosci; 2006 Jun; 126-127():285-91. PubMed ID: 16584925
[TBL] [Abstract][Full Text] [Related]
28. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation.
Miriyala S; Gongora Nieto MC; Mingone C; Smith D; Dikalov S; Harrison DG; Jo H
Circulation; 2006 Jun; 113(24):2818-25. PubMed ID: 16769910
[TBL] [Abstract][Full Text] [Related]
29. The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions.
Schäfer A; Schulz C; Fraccarollo D; Tas P; Leutke M; Eigenthaler M; Seidl S; Heider P; Ertl G; Massberg S; Bauersachs J
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):55-62. PubMed ID: 17082482
[TBL] [Abstract][Full Text] [Related]
30. The effect of peroxynitrite decomposition catalyst MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates: role in nitrate tolerance.
Mollace V; Muscoli C; Dagostino C; Giancotti LA; Gliozzi M; Sacco I; Visalli V; Gratteri S; Palma E; Malara N; Musolino V; Carresi C; Muscoli S; Vitale C; Salvemini D; Romeo F
Pharmacol Res; 2014 Nov; 89():29-35. PubMed ID: 25174989
[TBL] [Abstract][Full Text] [Related]
31. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
Haruna Y; Morita Y; Yada T; Satoh M; Fox DA; Kashihara N
Arthritis Rheum; 2007 Jun; 56(6):1827-35. PubMed ID: 17530711
[TBL] [Abstract][Full Text] [Related]
32. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM; Touyz RM
Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
[TBL] [Abstract][Full Text] [Related]
33. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.
Münzel T; Li H; Mollnau H; Hink U; Matheis E; Hartmann M; Oelze M; Skatchkov M; Warnholtz A; Duncker L; Meinertz T; Förstermann U
Circ Res; 2000 Jan; 86(1):E7-E12. PubMed ID: 10625313
[TBL] [Abstract][Full Text] [Related]
34. Role of endogenous hydrogen peroxide in the development of nitrate tolerance.
Ghatta S; Hemmer RB; Uppala S; O'Rourke ST
Vascul Pharmacol; 2007 Apr; 46(4):247-52. PubMed ID: 17157562
[TBL] [Abstract][Full Text] [Related]
35. Role of mitochondrial aldehyde dehydrogenase in nitrate tolerance.
DiFabio J; Ji Y; Vasiliou V; Thatcher GR; Bennett BM
Mol Pharmacol; 2003 Nov; 64(5):1109-16. PubMed ID: 14573760
[TBL] [Abstract][Full Text] [Related]
36. Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: implications for nitrate therapy in humans.
Wenzel P; Schulz E; Gori T; Ostad MA; Mäthner F; Schildknecht S; Göbel S; Oelze M; Stalleicken D; Warnholtz A; Münzel T; Daiber A
J Pharmacol Exp Ther; 2009 Jul; 330(1):63-71. PubMed ID: 19346443
[TBL] [Abstract][Full Text] [Related]
37. Prevention of nitrate tolerance by long-term treatment with statins.
Fontaine D; Otto A; Fontaine J; Berkenboom G
Cardiovasc Drugs Ther; 2003 Mar; 17(2):123-8. PubMed ID: 12975593
[TBL] [Abstract][Full Text] [Related]
38. Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH.
Deng S; Kruger A; Kleschyov AL; Kalinowski L; Daiber A; Wojnowski L
Free Radic Biol Med; 2007 Feb; 42(4):466-73. PubMed ID: 17275678
[TBL] [Abstract][Full Text] [Related]
39. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries.
Miller AA; Drummond GR; Schmidt HH; Sobey CG
Circ Res; 2005 Nov; 97(10):1055-62. PubMed ID: 16210546
[TBL] [Abstract][Full Text] [Related]
40. Distinct role of nox1, nox2, and p47phox in unstimulated versus angiotensin II-induced NADPH oxidase activity in human venous smooth muscle cells.
Chose O; Sansilvestri-Morel P; Badier-Commander C; Bernhardt F; Fabiani JN; Rupin A; Verbeuren TJ
J Cardiovasc Pharmacol; 2008 Feb; 51(2):131-9. PubMed ID: 18287880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
